Taiho Pharmaceutical

Taiho Pharmaceutical is a company engaged in the research, development, production, and sales of pharmaceutical products. The company primarily develops drugs in the field of oncology. It develops other pharmaceuticals, controlled medical devices, designated category medicines, Class II over-the-counter (OTC) drugs, specified Class II OTC drugs, and Class III OTC drugs; S-1 for the treatment of gastric cancer; TAS-102 for the treatment of colorectal cancer; as well as anticancer drugs for oncologists, other healthcare professionals, and patients. Additionally, it conducts research and development in the field of oncology.